Geopolitics Alpha

Live · last trade · ETFs, Alpaca IEX

8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer)

Published . Updated .

Key takeaways

  • 8-K - Drugs Made In America Acquisition II filed an 8-K with the SEC on Nov 18 (a notice of a material company event).
  • Exposed: DMIIU
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest and never sell or share it. See our privacy policy.

GEOPOLITICS ALPHA8-K - Drugs Made In AmericaAcquisition II Corp. (0002040475)(Filer)DMIIGEOPOLITICS ALPHA

8-K - Drugs Made In America Acquisition II filed an 8-K with the SEC on Nov 18 (a notice of a material company event).

Directly affected

  • DMII Drugs Made In America Acquisition II

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “drugs” (pharma and health) in this story.

  • XBI SPDR S&P Biotech ETF

    SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “drugs” (pharma and health) in this story.

  • LLY Eli Lilly and+25.1% 30d

    Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drugs” (pharma and health) in this story.

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drugs” (pharma and health) in this story.

  • PFE Pfizer+5.2% 30d

    Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drugs” (pharma and health) in this story.

  • MRK Merck+3.5% 30d

    Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drugs” (pharma and health) in this story.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
DMII+0.00%+0.00%baseafter closeafter closeafter closeafter close
XLV+2.00%+1.95%base-1.64%after closeafter closeafter close
XBI+7.54%+3.62%base-0.31%after closeafter closeafter close
LLY+1.56%+2.06%base-2.02%after closeafter closeafter close
JNJ+0.58%+2.60%base-1.30%after closeafter closeafter close
PFE+3.48%+1.55%base-1.16%after closeafter closeafter close
MRK+2.66%+3.05%base-2.68%after closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-11-18 AccNo: 0001477932-26-007137 Size: 223 KB Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 8.01: Other Events Item 9.01: Financial Statements…

Source: sec-edgar

How far Drugs Made In America Acquisition II (DMIIU) has moved since 18 Nov 2026

CompanyWhenMoveStatus
DMIIthree days earlier0.00%final price
DMIIfive days earlier0.00%final price
JNJthat day-1.30%still updating
JNJthree days earlier+2.60%final price
JNJfive days earlier+0.58%final price
LLYthat day-2.02%still updating
LLYthree days earlier+2.06%final price
LLYfive days earlier+1.56%final price
MRKthat day-2.68%still updating
MRKthree days earlier+3.05%final price
MRKfive days earlier+2.66%final price
PFEthat day-1.16%still updating
PFEthree days earlier+1.55%final price
PFEfive days earlier+3.48%final price
XBIthat day-0.31%still updating
XBIthree days earlier+3.62%final price
XBIfive days earlier+7.54%final price
XLVthat day-1.64%still updating
XLVthree days earlier+1.95%final price
XLVfive days earlier+2.00%final price

Trades by members of Congress and officials in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around Drugs Made In America Acquisition II (DMIIU)

Companies carried with this story

  • DMIIU Drugs Made In America Acquisition II

    For “8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer),” Drugs Made In America Acquisition II (DMIIU) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> DMIIU

Drugs Made In America Acquisition II (DMIIU)

The 18 Nov 2026 story “8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer)” names Drugs Made In America Acquisition II (DMIIU) because of this story.

Drugs Made In America Acquisition II (DMIIU) is on the page because SEC 8-K filing -> direct issuer disclosure -> DMIIU

How strong the case is around Drugs Made In America Acquisition II (DMIIU)

14 out of 100Price not final

“8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company. The price is not final yet.